Literature DB >> 28077868

Rheumatoid arthritis: TAK-ing the road to suppress inflammation in synovial fibroblasts.

Mojca Frank-Bertoncelj1, Steffen Gay1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28077868     DOI： 10.1038/nrrheum.2016.220

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  The Activation of IL-1-Induced Enhancers Depends on TAK1 Kinase Activity and NF-κB p65.

Authors:  Liane Jurida; Johanna Soelch; Marek Bartkuhn; Katja Handschick; Helmut Müller; Doris Newel; Axel Weber; Oliver Dittrich-Breiholz; Heike Schneider; Sabin Bhuju; Vera V Saul; M Lienhard Schmitz; Michael Kracht
Journal:  Cell Rep       Date:  2015-02-05       Impact factor: 9.423

2.  Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts.

Authors:  Angela Lee; Yu Qiao; Galina Grigoriev; Janice Chen; Kyung-Hyun Park-Min; Sung Ho Park; Lionel B Ivashkiv; George D Kalliolias
Journal:  Arthritis Rheum       Date:  2013-04

Review 3.  IL-6 biology: implications for clinical targeting in rheumatic disease.

Authors:  Leonard H Calabrese; Stefan Rose-John
Journal:  Nat Rev Rheumatol       Date:  2014-08-19       Impact factor: 20.543

Review 4.  Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?

Authors:  S Gay; R E Gay; W J Koopman
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

5.  The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon.

Authors:  Sanna Rosengren; Maripat Corr; Gary S Firestein; David L Boyle
Journal:  Ann Rheum Dis       Date:  2011-11-25       Impact factor: 19.103

6.  IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.

Authors:  M Hashizume; N Hayakawa; M Mihara
Journal:  Rheumatology (Oxford)       Date:  2008-09-11       Impact factor: 7.580

7.  Prolonged tumor necrosis factor α primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin.

Authors:  Christopher Sohn; Angela Lee; Yu Qiao; Konstantinos Loupasakis; Lionel B Ivashkiv; George D Kalliolias
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

8.  Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage.

Authors:  Adam P Croft; Amy J Naylor; Jennifer L Marshall; Debbie L Hardie; Birgit Zimmermann; Jason Turner; Guillaume Desanti; Holly Adams; Adrian I Yemm; Ulf Müller-Ladner; Jean-Michel Dayer; Elena Neumann; Andrew Filer; Christopher D Buckley
Journal:  Arthritis Res Ther       Date:  2016-11-18       Impact factor: 5.156

Review 9.  New learnings on the pathophysiology of RA from synovial biopsies.

Authors:  Costantino Pitzalis; Stephen Kelly; Frances Humby
Journal:  Curr Opin Rheumatol       Date:  2013-05       Impact factor: 5.006

10.  Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation.

Authors:  Douglas S Jones; Anne P Jenney; Jennifer L Swantek; John M Burke; Douglas A Lauffenburger; Peter K Sorger
Journal:  Nat Chem Biol       Date:  2016-10-31       Impact factor: 16.174
  10 in total
  4 in total

Review 1.  The Application of Single-Cell RNA Sequencing in Studies of Autoimmune Diseases: a Comprehensive Review.

Authors:  Mingming Zhao; Jiao Jiang; Ming Zhao; Christopher Chang; Haijing Wu; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-25       Impact factor: 8.667

2.  Rheumatoid arthritis-relevant DNA methylation changes identified in ACPA-positive asymptomatic individuals using methylome capture sequencing.

Authors:  Xiaojian Shao; Marie Hudson; Ines Colmegna; Celia M T Greenwood; Marvin J Fritzler; Philip Awadalla; Tomi Pastinen; Sasha Bernatsky
Journal:  Clin Epigenetics       Date:  2019-07-31       Impact factor: 6.551

3.  VRK2 activates TNFα/NF-κB signaling by phosphorylating IKKβ in pancreatic cancer.

Authors:  Jionghuang Chen; Kexiong Qiao; Chaolei Zhang; Xinyang Zhou; Qian Du; Yuezhen Deng; Liping Cao
Journal:  Int J Biol Sci       Date:  2022-01-09       Impact factor: 6.580

4.  Synovial fibroblast-targeting liposomes encapsulating an NF-κB-blocking peptide ameliorates zymosan-induced synovial inflammation.

Authors:  Changcheng You; Jianing Zu; Xiaoqi Liu; Pengyu Kong; Chengchao Song; Rongzhi Wei; Changlong Zhou; Yufu Wang; Jinglong Yan
Journal:  J Cell Mol Med       Date:  2018-01-30       Impact factor: 5.310
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.